Which Clear Eyes Drops Are Recalled? Lot 2552A

Only Clear Eyes Maximum Itchy Eye Relief in the 0.5 fl oz (15 mL) bottle from lot 2552A, expiring September 30, 2027, is included in this Clear Eyes recall. The package carries NDC 67172-999-01 and UPC 6 78112 65920 3. The supplied FDA records do not show a recall of the entire Clear Eyes brand or every lot of this product.

Enter the lot, UPC, NDC, or recall number from your package; the checker separates the Clear Eyes recall from the Rohto and Lupin events.

The Recalled Clear Eyes Package Has Six Matching Identifiers

The FDA enforcement record identifies the recalled package as follows:

Identifier	Recalled Package
Product	Clear Eyes Maximum Itchy Eye Relief
Size	0.5 fl oz (15 mL)
Lot	2552A
Expiration	September 30, 2027
NDC	67172-999-01
UPC	6 78112 65920 3
Recall	D-0766-2026

The UPC may appear without spaces as 678112659203. The FDA reports that 39,060 bottles were distributed nationwide in the United States. That number describes distribution; it is not a count of contaminated bottles, infections, injuries, or adverse reactions. Review FDA Event 99532.

Start with the complete product name. A different Clear Eyes variety is not included merely because its label resembles Maximum Itchy Eye Relief. Then compare the size, lot, expiration date, NDC, and UPC.

The lot must read 2552A exactly. It is not the same as 2552, 2552B, or a longer code containing similar characters. Check the bottle and any carton you retained, but do not assume the code must appear in a particular location; the supplied evidence does not establish a universal placement.

Match the lot with the expiration date. An expiration date by itself is not a unique recall identifier. A bottle expiring September 30, 2027 is not confirmed as recalled unless its other details, especially the product and lot, also match.

The openFDA result associates Clear Eyes Maximum Itchy Eye Relief and lot 2552A with recall D-0766-2026. OpenFDA warns that its data are unvalidated and should not be used to make medical-care decisions, so use it as a structured cross-check rather than a substitute for the enforcement record. View the openFDA result for D-0766-2026.

A Different Clear Eyes Lot Is Not Listed in This Recall

A bottle with a different Clear Eyes product name or lot number is not identified under recall D-0766-2026. That is narrower than saying the bottle is guaranteed safe or could never become subject to another notice.

Do not return or discard every Clear Eyes product solely because of the brand name. Conversely, do not check only the product name and overlook the lot. The available record covers one product configuration and one lot: Clear Eyes Maximum Itchy Eye Relief, 15 mL, lot 2552A.

If the lot is missing, smudged, or unreadable, the bottle cannot be cleared using the available identifiers. Keep it and its packaging out of use while a pharmacist, retailer, distributor, or manufacturer representative helps identify it.

The Recall Concerns Lack of Sterility Assurance

The official recall reason is lack of assurance of sterility due to potential contamination. This means sterility could not be assured; it does not establish that every recalled bottle, or any particular bottle, contained a contaminant.

The supplied FDA record does not name a bacterium or fungus. It also does not identify a confirmed contaminated bottle, a particular manufacturing defect, a failed test, or the proportion of bottles that may have been affected. Claims about a specific organism or source would therefore be speculation.

An August 21, 2026 NBC News report quoted a Prestige spokesperson as saying the affected product had not been confirmed contaminated and that no injuries had been reported at that time. Those are dated, attributed statements rather than a guarantee about later reports or an individual bottle. Read the NBC News report and company response.

A matching bottle should still be removed from use. Lack of confirmed contamination does not restore assurance that the product is sterile.

FDA Classified the Voluntary Recall as Class II

Prestige Brands Holdings voluntarily initiated the firm-led recall on July 29, 2026. FDA classified it as Class II on August 14, 2026. The enforcement record does not state that FDA ordered or initiated the recall.

A Class II classification means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, while serious harm is considered unlikely. It does not mean there is no risk, nor does it prove that anyone was harmed.

The separate dates describe different milestones. July 29 is the company’s recall-initiation date; August 14 is FDA’s classification date. The recall can be identified by either FDA Event 99532 or recall D-0766-2026.

Stop Using a Bottle That Matches Lot 2552A

If the product, size, and lot match, stop using the bottle and set it aside so it cannot be used accidentally. Keep the bottle, carton, receipt, and other packaging while confirming the current return or disposal procedure.

The supplied official record does not establish one universal refund, replacement, or disposal policy. Retailer and distributor procedures may differ. Check the current FDA listing, then ask the retailer, distributor, manufacturer, or a pharmacist what they require before discarding identifying materials.

Secondary reporting in August 2026 said consumers were advised to return the affected product for a refund. That does not establish guaranteed reimbursement through every seller. Confirm current terms with the party handling the return.

A bottle with a different lot should not be altered or interpreted to make its code fit 2552A. If the code cannot be read, keep the product out of use until it can be identified rather than guessing.

Prior Use Does Not Prove Exposure to Contamination

If you already used drops from lot 2552A, discontinue further use of that bottle. Prior use does not establish that the drops were contaminated, and a recall database cannot calculate an individual user’s risk.

Contact a healthcare professional if you develop vision changes or symptoms you believe could indicate an eye infection. Sudden vision change, eye pain, or light sensitivity warrants same-day clinical attention under Dry Eye Watch’s medical-information notice. See the site’s medical-information terms.

When seeking care or reporting a concern, retain these details if available:

• Full product name and bottle size
• Lot number and expiration date
• NDC and UPC
• When and how often the drops were used
• When symptoms began
• The bottle and carton

The absence of symptoms does not let a recall checker determine whether individualized follow-up is needed. A pharmacist, optometrist, ophthalmologist, physician, or other qualified healthcare professional can assess a specific exposure or symptom.

Rohto and Lupin Drops Belong to Separate Recall Events

The Rohto Cooling Eye Drops and Lupin prednisolone acetate ophthalmic suspension recalls are separate from the Clear Eyes event. They involve different companies, products, lots, and FDA event numbers.

Product Or Event	FDA Event	Distinction
Clear Eyes Maximum Itchy Eye Relief	99532	Lot 2552A
Specified Rohto Cooling Eye Drops	99440	Separate products and lots
Lupin prednisolone acetate suspension	99144	Separate prescription product

The supplied material does not provide the Rohto or Lupin lot numbers, UPCs, expiration dates, or universal return instructions. The checker therefore will not label an unrecognized Rohto or Lupin code as “not recalled.” It directs those packages to their official event records instead of making an unsupported determination.

For Rohto products, compare the complete package against FDA Event 99440. For Lupin prednisolone acetate ophthalmic suspension, use FDA Event 99144. Neither event expands recall D-0766-2026 to additional Clear Eyes products.

The Clear Eyes Event Was Ongoing on August 26, 2026

FDA listed recall D-0766-2026 as ongoing, with no termination date, when the enforcement record was checked on August 26, 2026. Recall status can change, so verify the current listing before relying on that dated status.

Search by D-0766-2026 or open Event 99532, then confirm that the result names Clear Eyes Maximum Itchy Eye Relief, 15 mL, lot 2552A. Broad searches for recalled eye drops can mix the Clear Eyes, Rohto, and Lupin events even though their package identifiers are not interchangeable.

Clear Eyes Recall Questions

Are All Clear Eyes Eye Drops Recalled?

No. The supplied FDA record identifies only Clear Eyes Maximum Itchy Eye Relief, 15 mL, lot 2552A. It does not list the entire brand, every Clear Eyes product, or every lot of Maximum Itchy Eye Relief.

Was Contamination Confirmed?

The FDA reason is lack of assurance of sterility due to potential contamination. The supplied record does not identify confirmed contamination in a particular bottle or name a specific organism.

What If Only the Expiration Date Matches?

An expiration date of September 30, 2027 is not enough by itself. Compare the full product name, 15 mL size, lot 2552A, NDC 67172-999-01, and UPC 678112659203.

What If the Lot Number Cannot Be Read?

Do not treat an unreadable code as a negative result. Keep the bottle and packaging out of use while a pharmacist, retailer, distributor, or manufacturer representative helps identify it.